Bio-Rad Laboratories (BIO) Debt/Assets Ratio: History & Chart

Bio-Rad Laboratories, Inc.(BIO)

Medical - Devices · Hercules, CA

$381.09-5.02 (-1.30%)

Delayed quote: Sep 8, 2026, 3:20 PM EDT

About Bio-Rad Laboratories, Inc.

Bio-Rad Laboratories, Inc., established in 1952 and headquartered in Hercules, California, operates as a global provider of life science research and clinical diagnostic products. Its operations span across the United States, Canada, Europe, Asia, and Latin America. The company is organized into two primary divisions: Life Science and Clinical Diagnostics. The Life Science division is responsible for developing, manufacturing, and commercializing a diverse array of reagents, equipment, and laboratory instruments. These products are crucial for various research methodologies, biopharmaceutical manufacturing processes, and food quality testing. This segment focuses on specialized areas within the life sciences, including proteomics, genomics, biopharmaceutical production, cellular biology, and food safety. Its clientele encompasses academic institutions (such as universities and medical schools), industrial research organizations, government agencies, pharmaceutical companies, biotechnology firms, food producers, and food testing laboratories. In contrast, the Clinical Diagnostics division designs, produces, sells, and supports a comprehensive suite of test systems, informatics solutions, diagnostic kits, and specialized quality control products for clinical laboratories. This segment provides reagents, instruments, and software specifically tailored for particular niches within the in vitro diagnostics market. Its customer base includes reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, and transfusion laboratories. Beyond these core segments, Bio-Rad also offers systems and products designed to separate complex chemical and biological materials, as well as to identify, analyze, and purify their individual components. The company distributes its extensive product portfolio through a combination of its direct sales force and a network of third-party distributors, agents, brokers, and resellers.

Hercules, CA

7,450 employees

www.bio-rad.com

Healthcare / Medical - Devices

Sector: Healthcare
Industry: Medical - Devices
CEO: Norman D. Schwartz

View full financials

BIO Debt to Assets Ratio Metrics

DEBT TO ASSETS RATIO

11.74%

DEBT TO ASSETS RATIO AVG TTM

13.69%

DEBT TO ASSETS RATIO AVG 3Y

13.14%

DEBT TO ASSETS RATIO AVG 5Y

12.41%

DEBT TO ASSETS RATIO AVG 10Y

9.92%

DEBT TO ASSETS RATIO AVG 15Y

11.07%

DEBT TO ASSETS RATIO AVG 20Y

15.60%

CURRENT VS TTM AVG

-14.24%

CURRENT VS 3Y AVG

-10.67%

CURRENT VS 5Y AVG

-5.41%

CURRENT VS 10Y AVG

+18.34%

CURRENT VS 15Y AVG

+6.07%

CURRENT VS 20Y AVG

-24.73%

SECTOR MEDIAN · HEALTHCARE

0.28%

median of 90 covered companies

CURRENT VS SECTOR MEDIAN

+4093.26%

vs the sector median at left

NAME	MARKET CAP	DEBT TO ASSETS RATIO	TTM	3Y	5Y
Bio-Rad Laboratories, Inc. (BIO)	$10.26B	11.74%	13.69%	13.14%	12.41%
Molina Healthcare, Inc. (MOH)vs ›	$10.29B	0.25%	N/A	N/A	N/A
Globus Medical, Inc. (GMED)vs ›	$10.22B	0.02%	N/A	N/A	N/A
Henry Schein, Inc. (HSIC)vs ›	$10.16B	0.34%	N/A	N/A	N/A
The Ensign Group, Inc. (ENSG)vs ›	$10.02B	0.39%	N/A	N/A	N/A
Universal Health Services, Inc. (UHS)vs ›	$10.52B	0.33%	N/A	N/A	N/A
Insulet Corp. (PODD)vs ›	$9.86B	0.30%	N/A	N/A	N/A
Align Technology, Inc. (ALGN)vs ›	$11.11B	0.02%	N/A	N/A	N/A
Tempus AI, Inc. (TEM)vs ›	$11.21B	0.61%	N/A	N/A	N/A
Bio-Techne Corporation (TECH)vs ›	$11.32B	0.11%	N/A	N/A	N/A

NAME

MARKET CAP

DEBT TO ASSETS RATIO

TTM

Bio-Rad Laboratories, Inc. (BIO)

$10.26B

11.74%

13.69%

13.14%

12.41%

Molina Healthcare, Inc. (MOH)vs ›

$10.29B

0.25%

N/A

Globus Medical, Inc. (GMED)vs ›

$10.22B

0.02%

N/A

Henry Schein, Inc. (HSIC)vs ›

$10.16B

0.34%

N/A

The Ensign Group, Inc. (ENSG)vs ›

$10.02B

0.39%

N/A

Universal Health Services, Inc. (UHS)vs ›

$10.52B

0.33%

N/A

Insulet Corp. (PODD)vs ›

$9.86B

0.30%

N/A

Align Technology, Inc. (ALGN)vs ›

$11.11B

0.02%

N/A

Tempus AI, Inc. (TEM)vs ›

$11.21B

0.61%

N/A

Bio-Techne Corporation (TECH)vs ›

$11.32B

0.11%

N/A

Debt to Assets Ratio FAQ

What is the debt to assets ratio for Bio-Rad Laboratories, Inc. (BIO)?

The debt to assets ratio for BIO stock is 11.74%.

Is Bio-Rad Laboratories, Inc.'s debt to assets ratio high or low?

The debt to assets ratio of 11.74% is in line with its 5-year average of 12.41%, near the high end of its 5-year range (1.18%–14.68%).

What is the TTM average debt to assets ratio for Bio-Rad Laboratories, Inc. (BIO)?

The TTM average debt to assets ratio for BIO stock is 13.69%.

What is the 3Y average debt to assets ratio for Bio-Rad Laboratories, Inc. (BIO)?

The 3Y average debt to assets ratio for BIO stock is 13.14%.

What is the 5Y average debt to assets ratio for Bio-Rad Laboratories, Inc. (BIO)?

The 5Y average debt to assets ratio for BIO stock is 12.41%.

What is the 10Y average debt to assets ratio for Bio-Rad Laboratories, Inc. (BIO)?

The 10Y average debt to assets ratio for BIO stock is 9.92%.

What is the 15Y average debt to assets ratio for Bio-Rad Laboratories, Inc. (BIO)?

The 15Y average debt to assets ratio for BIO stock is 11.07%.

What is the 20Y average debt to assets ratio for Bio-Rad Laboratories, Inc. (BIO)?

The 20Y average debt to assets ratio for BIO stock is 15.60%.

DATE	DEBT TO ASSETS RATIO
2026-06-30	11.74%
2026-03-31	14.08%
2025-12-31	14.48%
2025-09-30	14.39%
2025-06-30	13.77%
2025-03-31	14.38%
2024-12-31	14.68%
2024-09-30	13.09%
2024-06-30	14.37%
2024-03-31	11.10%
2023-12-31	11.43%
2023-09-30	11.81%
2023-06-30	11.54%
2023-03-31	10.11%
2022-12-31	10.28%
2022-09-30	11.44%
2022-06-30	10.97%
2022-03-31	9.77%
2021-12-31	1.25%
2021-09-30	1.18%
2021-06-30	1.47%
2021-03-31	1.66%
2020-12-31	1.74%
2020-09-30	5.37%
2020-06-30	6.40%
2020-03-31	7.47%
2019-12-31	8.13%
2019-09-30	9.28%
2019-06-30	8.65%
2019-03-31	9.71%
2018-12-31	7.83%
2018-09-30	6.56%
2018-06-30	6.90%
2018-03-31	7.00%
2017-12-31	10.18%
2017-09-30	10.39%
2017-06-30	10.50%
2017-03-31	11.00%
2016-12-31	11.28%
2016-09-30	10.81%
2016-06-30	11.21%
2016-03-31	11.57%
2015-12-31	11.70%
2015-09-30	11.89%
2015-06-30	12.37%
2015-03-31	13.11%
2014-12-31	13.05%
2014-09-30	12.91%
2014-06-30	12.61%
2014-03-31	12.71%
2013-12-31	12.91%
2013-09-30	13.33%
2013-06-30	21.09%
2013-03-31	21.24%
2012-12-31	21.32%
2012-09-30	22.18%
2012-06-30	23.13%
2012-03-31	22.98%
2011-12-31	23.65%
2011-09-30	24.66%
2011-06-30	24.07%
2011-03-31	25.49%
2010-12-31	31.48%
2010-09-30	27.69%
2010-06-30	29.44%
2010-03-31	29.20%
2009-12-31	29.30%
2009-09-30	30.02%
2009-06-30	31.75%
2009-03-31	23.04%
2008-12-31	22.36%
2008-09-30	22.74%
2008-06-30	21.70%
2008-03-31	22.31%
2007-12-31	23.20%
2007-09-30	25.17%
2007-06-30	26.03%
2007-03-31	26.76%
2006-12-31	26.86%
2006-09-30	28.19%
2006-06-30	28.80%
2006-03-31	30.38%
2005-12-31	30.07%
2005-09-30	30.49%
2005-06-30	31.41%
2005-03-31	31.13%
2004-12-31	31.75%
2004-09-30	21.46%
2004-06-30	23.08%
2004-03-31	23.53%
2003-12-31	23.80%
2003-09-30	25.37%
2003-06-30	14.49%
2003-03-31	14.88%
2002-12-31	15.71%
2002-09-30	20.79%

DATE

DEBT TO ASSETS RATIO

2026-06-30

11.74%

2026-03-31

14.08%

2025-12-31

14.48%

2025-09-30

14.39%

2025-06-30

13.77%

2025-03-31

14.38%

2024-12-31

14.68%

2024-09-30

13.09%

2024-06-30

14.37%

2024-03-31

11.10%

2023-12-31

11.43%

2023-09-30

11.81%

2023-06-30

11.54%

2023-03-31

10.11%

2022-12-31

10.28%

2022-09-30

11.44%

2022-06-30

10.97%

2022-03-31

9.77%

2021-12-31

1.25%

2021-09-30

1.18%

2021-06-30

1.47%

2021-03-31

1.66%

2020-12-31

1.74%

2020-09-30

5.37%

2020-06-30

6.40%

2020-03-31

7.47%

2019-12-31

8.13%

2019-09-30

9.28%

2019-06-30

8.65%

2019-03-31

9.71%

2018-12-31

7.83%

2018-09-30

6.56%

2018-06-30

6.90%

2018-03-31

7.00%

2017-12-31

10.18%

2017-09-30

10.39%

2017-06-30

10.50%

2017-03-31

11.00%

2016-12-31

11.28%

2016-09-30

10.81%

2016-06-30

11.21%

2016-03-31

11.57%

2015-12-31

11.70%

2015-09-30

11.89%

2015-06-30

12.37%

2015-03-31

13.11%

2014-12-31

13.05%

2014-09-30

12.91%

2014-06-30

12.61%

2014-03-31

12.71%

2013-12-31

12.91%

2013-09-30

13.33%

2013-06-30

21.09%

2013-03-31

21.24%

2012-12-31

21.32%

2012-09-30

22.18%

2012-06-30

23.13%

2012-03-31

22.98%

2011-12-31

23.65%

2011-09-30

24.66%

2011-06-30

24.07%

2011-03-31

25.49%

2010-12-31

31.48%

2010-09-30

27.69%

2010-06-30

29.44%

2010-03-31

29.20%

2009-12-31

29.30%

2009-09-30

30.02%

2009-06-30

31.75%

2009-03-31

23.04%

2008-12-31

22.36%

2008-09-30

22.74%

2008-06-30

21.70%

2008-03-31

22.31%

2007-12-31

23.20%

2007-09-30

25.17%

2007-06-30

26.03%

2007-03-31

26.76%

2006-12-31

26.86%

2006-09-30

28.19%

2006-06-30

28.80%

2006-03-31

30.38%

2005-12-31

30.07%

2005-09-30

30.49%

2005-06-30

31.41%

2005-03-31

31.13%

2004-12-31

31.75%

2004-09-30

21.46%

2004-06-30

23.08%

2004-03-31

23.53%

2003-12-31

23.80%

2003-09-30

25.37%

2003-06-30

14.49%

2003-03-31

14.88%

2002-12-31

15.71%

2002-09-30

20.79%

Debt to Assets Ratio: 11.74%

BIO Debt to Assets Ratio

BIO Average Debt to Assets Ratio Chart

BIO Current vs Average Debt to Assets Ratio Chart

BIO Debt to Assets Ratio Metrics

BIO Competitors' Debt to Assets Ratio

Leverage Ratios Comparison

Debt to Assets Ratio Formula & Definition

Debt to Assets Ratio FAQ

BIO Debt to Assets Ratio History

Related Metrics